Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. Frequent sites involve LYMPH NODES, skin, and bones. It most commonly presents as leukemia.

Descriptor ID	D015452
MeSH Number(s)	C04.557.337.428.600.600 C15.604.515.560.600.600 C20.683.515.528.600.600
Concept/Terms	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Precursor B Cell Lymphoblastic Leukemia Lymphoma Pre B-ALL Pre-B ALL Pre B ALL Precursor B-Cell Lymphoblastic Leukemia Precursor B Cell Lymphoblastic Leukemia Precursor B-Cell Lymphoblastic Lymphoma Precursor B Cell Lymphoblastic Lymphoma Leukemia, Pre-B-Cell Leukemia, Pre B Cell Leukemias, Pre-B-Cell Pre-B-Cell Leukemias Pre-B-Cell Leukemia Pre B Cell Leukemia

Below are MeSH descriptors whose meaning is more general than "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Leukemia [C04.557.337]
Leukemia, Lymphoid [C04.557.337.428]
Precursor Cell Lymphoblastic Leukemia-Lymphoma [C04.557.337.428.600]
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma [C04.557.337.428.600.600]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Leukemia, Lymphoid [C15.604.515.560]
Precursor Cell Lymphoblastic Leukemia-Lymphoma [C15.604.515.560.600]
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma [C15.604.515.560.600.600]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Leukemia, Lymphoid [C20.683.515.528]
Precursor Cell Lymphoblastic Leukemia-Lymphoma [C20.683.515.528.600]
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma [C20.683.515.528.600.600]

Below are MeSH descriptors whose meaning is related to "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma".

Below are MeSH descriptors whose meaning is more specific than "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma" by people in this website by year, and whether "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma" was a major or minor topic of these publications.

Bar chart showing 11 publications over 9 distinct years, with a maximum of 2 publications in 2008 and 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
2004	0	1	1
2005	1	0	1
2008	2	0	2
2016	1	0	1
2017	1	1	2
2020	1	0	1
2021	1	0	1
2022	1	0	1

Below are the most recent publications written about "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma" by people in Profiles.

Yang Y, Bi X, Gergis M, Yi D, Hsu J, Gergis U. Allogeneic Chimeric Antigen Receptor T Cells for Hematologic Malignancies. Hematol Oncol Stem Cell Ther. 2022 Dec 15; 15(3):112-116.

View in: PubMed
Mangum DS, Meyer JA, Mason CC, Shams S, Maese LD, Gardiner JD, Downie JM, Pei D, Cheng C, Gleason A, Luo M, Pui CH, Aplenc R, Hunger SP, Loh M, Greaves M, Trede N, Raetz E, Frazer JK, Mullighan CG, Engel ME, Miles RR, Rabin KR, Schiffman JD. Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia. JAMA Oncol. 2021 Oct 01; 7(10):1521-1528.

View in: PubMed
Germans SK, Kulak O, Koduru P, Oliver D, Gagan J, Patel P, Anderson LD, Fuda FS, Chen W, Jaso JM. Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma-A Unique Entity. Am J Clin Pathol. 2020 11 04; 154(6):816-827.

View in: PubMed
Fraint E, Miller R, Walter A. Posterior Reversible Encephalopathy Syndrome and Cerebral Sinus Thrombosis in a Case of Pediatric B-Cell ALL. J Pediatr Hematol Oncol. 2017 03; 39(2):e71-e73.

View in: PubMed
Quagliano A, Gopalakrishnapillai A, Barwe SP. Epigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia. Leuk Res. 2017 05; 56:36-43.

View in: PubMed
Cheng Y, Chikwava K, Wu C, Zhang H, Bhagat A, Pei D, Choi JK, Tong W. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors. J Clin Invest. 2016 Apr 01; 126(4):1267-81.

View in: PubMed
Mantadakis E, Katragkou A, Papadaki E, Papadhimitriou S, Paterakis G, Stiakaki E, Kalmanti M. Spinal cord compression in an adolescent with relapsed B-precursor acute lymphoblastic leukemia and mental neuropathy. Int J Hematol. 2008 Oct; 88(3):294-298.

View in: PubMed
Young FM, Campbell A, Emo KL, Jansson J, Wang PY, Jordan CT, Mullen CA. High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells. Biol Blood Marrow Transplant. 2008 Jun; 14(6):622-30.

View in: PubMed
Abrams MT, Robertson NM, Litwack G, Wickstrom E. Evaluation of glucocorticoid sensitivity in 697 pre-B acute lymphoblastic leukemia cells after overexpression or silencing of MAP kinase phosphatase-1. J Cancer Res Clin Oncol. 2005 Jun; 131(6):347-54.

View in: PubMed
Kersun LS, Wimmer RS, Hoot AC, Meadows AT. Secondary malignant neoplasms of the bladder after cyclophosphamide treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer. 2004 Mar; 42(3):289-91.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement